Description
SEMA – Semaglutide (5 mg) is a high-purity glucagon-like peptide-1 (GLP-1) analog developed exclusively for scientific and preclinical research. It is structurally engineered to mimic native GLP-1 while offering increased stability and a longer half-life, making it suitable for studies involving metabolic function, appetite regulation, insulin activity, and weight control.
Researchers have shown growing interest in Semaglutide for its role in:
Glucose homeostasis and insulin secretion
Appetite suppression pathways
Lipid metabolism and body weight studies
Neuroendocrine signaling
Its prolonged activity profile enables fewer dosing intervals in lab models, which supports efficient data collection over extended study periods. The peptide is commonly explored alongside other metabolic modulators to investigate synergistic effects in endocrine-related conditions.
